Bristol-Myers Squibb Co (NYSE: BMY) kicked off on Monday, down -0.92% from the previous trading day, before settling in for the closing price of $52.15. Over the past 52 weeks, BMY has traded in a range of $42.52-$63.33.
While this was happening, its average annual earnings per share was recorded 465.41%. With a float of $2.03 billion, this company’s outstanding shares have now reached $2.04 billion.
Bristol-Myers Squibb Co (BMY) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Bristol-Myers Squibb Co is 0.18%, while institutional ownership is 81.03%. The most recent insider transaction that took place on Sep 02 ’25, was worth 2,650,480. In this transaction EVP, Chief Financial Officer of this company sold 56,000 shares at a rate of $47.33, taking the stock ownership to the 167,379 shares. Before that another transaction happened on Sep 02 ’25, when Company’s Officer proposed sale 56,000 for $47.30, making the entire transaction worth $2,648,800.
Bristol-Myers Squibb Co (BMY) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 1.67 earnings per share (EPS), higher than consensus estimate (set at 1.47) by 0.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.49 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 465.41% per share during the next fiscal year.
Bristol-Myers Squibb Co (NYSE: BMY) Trading Performance Indicators
Take a look at Bristol-Myers Squibb Co’s (BMY) current performance indicators. Last quarter, stock had a quick ratio of 1.17. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.19. Likewise, its price to free cash flow for the trailing twelve months is 6.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.96, a number that is poised to hit 1.61 in the next quarter and is forecasted to reach 5.99 in one year’s time.
Technical Analysis of Bristol-Myers Squibb Co (BMY)
Let’s dig in a bit further. During the last 5-days, its volume was 18.6 million. That was better than the volume of 13.94 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 90.56%.
During the past 100 days, Bristol-Myers Squibb Co’s (BMY) raw stochastic average was set at 91.59%, which indicates a significant increase from 88.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.10 in the past 14 days, which was higher than the 1.04 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $46.25, while its 200-day Moving Average is $49.06. However, in the short run, Bristol-Myers Squibb Co’s stock first resistance to watch stands at $52.16. Second resistance stands at $52.66. The third major resistance level sits at $52.91. If the price goes on to break the first support level at $51.42, it is likely to go to the next support level at $51.17. The third support level lies at $50.67 if the price breaches the second support level.
Bristol-Myers Squibb Co (NYSE: BMY) Key Stats
The company with the Market Capitalisation of 105.19 billion has total of 2,035,753K Shares Outstanding. Its annual sales at the moment are 48,300 M in contrast with the sum of -8,948 M annual income. Company’s last quarter sales were recorded 12,222 M and last quarter income was 2,201 M.
